Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the CRISPR And Cas Gene Market Grown from 2024 to 2025?

The market size of the CRISPR and Cas gene has expanded exceptionally in the past few years. It is forecasted to grow from $3.99 billion in 2024 to $4.85 billion in 2025, with a compound annual growth rate (CAGR) of 21.7%. The substantial growth during the historic period is a result of heightened consumer awareness, changes in consumer values, increased celebrity endorsements, the burgeoning popularity of veganism, and a substantial influence of social media.

What Growth Rate Is Anticipated for the CRISPR And Cas Gene Market in the Coming Years?

The market size for the CRISPR and Cas gene is predicted to experience remarkable growth in the upcoming years. With an anticipated compound annual growth rate (CAGR) of 22.2%, it is set to reach $10.81 billion by 2029. Factors contributing to the expected growth in the forecast period are global prohibition expansions, increasing conscious consumerism, the revelation of new brands, educational endeavors regarding consumers, and beauty inclusivity. Significant trends throughout this period are slated to be advancements in technology, product innovations, a circular beauty economy, the men’s grooming segment, and emphasis on social justice and ethical sourcing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13632&type=smp

Who Are the Leading Companies in the CRISPR And Cas Gene Market?

Major companies operating in the Crispr and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group PLC, Beam Therapeutics Inc., Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc., Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc.

What Are the Key Drivers of the CRISPR And Cas Gene Market?

Increasing emphasis on tailored treatment methods is projected to stimulate the expansion of the CRISPR and Cas gene markets. Tailored therapy is a medical approach that utilises a person’s genetic makeup to provide guidance on disease diagnosis, treatment, and prevention. CRISPR, including the Cas gene – especially Cas9, is implemented in tailored medicine, allowing for exact changes to a person’s genetic code and offering potential for revolutionary advancements in creating custom-made therapies for genetic disorders, cancer, and numerous medical conditions. For example, in January 2023, the US-based professional membership organization, Personalized Medicine Coalition reported that the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) had given approval to 37 new molecular entities (NMEs) in 2022. Out of these 35 therapeutic NMEs, almost 34% – equating to 12 of them, are categorized as tailored medicines by the Personalized Medicine Coalition (PMC). Consequently, the growing need for tailored therapy will fuel the expansion of the CRISPR and Cas gene markets.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13632&type=smp

What Are the Key Market Segments in the CRISPR And Cas Gene Industry?

The crispr and cas gene market covered in this report is segmented –

1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types

2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis

3) By Application: Clinical, Financial, Operational And Administrative

4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)

Subsegments:

1) By Kits And Enzymes: CRISPR Kits, Cas Enzymes, Grna Synthesis Kits

2) By Libraries: CRISPR Libraries For Gene Knockout, CRISPR Libraries For Gene Activation, Sgrna Libraries

3) By Design Tools: Online Design Platforms, Software For CRISPR Guide RNA Design, Custom Design Services

4) By Antibodies: Antibodies For Cas Proteins, Antibodies For Detection Of Edited Cells, Secondary Antibodies For Immunoassays

5) By Other Product Types: Delivery Systems, CRISPR-Related Consumables, Control Plasmids And Reagents

What Are the Latest Trends in the CRISPR And Cas Gene Market?

Leading businesses in the CRISPR and Cas gene markets are driving innovation with the creation of novel therapies like CRISPR-based cellular gene treatment, aiming to elevate their product range and secure a market edge. The method of CRISPR-cell based gene therapy uses the CRISPR gene modification technique to amend or rectify genetic sequences within cells. This innovative strategy marks a promising solution for genetic disorders, diseases and various health conditions at the cellular level. As an example, in December 2023, Vertex Pharmaceuticals Incorporated, a biopharmaceutical firm based in the U.S., achieved approval from the U.S. Food and Drug Administration (FDA) for their drug, CASGEVY (exagamglogene autotemcel [exa-cel]). This drug, a CRISPR/Cas9 genome-edited gene therapy, treats sickle cell disease (SCD) in patients aged 12 and up who frequently experience vaso-occlusive crises. CASGEVY, one of the first medications of its kind, has the potential to be a life-changing, one-time treatment for eligible sickle cell patients. The application of CASGEVY requires specialist training in stem cell transplantation. Therefore, Vertex is working alongside multiple seasoned institutions to establish a network of independent, certified treatment centers (ATCs) scattered across America to accommodate patients requiring CASGEVY.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

What Are the Key Regional Markets in the CRISPR And Cas Gene Industry?

North America was the largest region in the CRISPR and Cas gene market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13632

This Report Delivers Insight On:

1. How big is the crispr and cas gene market, and how is it changing globally?

2. Who are the major companies in the crispr and cas gene market, and how are they performing?

3. What are the key opportunities and risks in the crispr and cas gene market right now?

4. Which products or customer segments are growing the most in the crispr and cas gene market?

5. What factors are helping or slowing down the growth of the crispr and cas gene market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model